MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Two Implementation Strategies for the Collection of Electronic Patient-Reported Outcomes Among Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma
- Status
- RECRUITING
- Phase
- N/A
Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment
- Status
- RECRUITING
- Phase
- N/A
Self-administration of Subcutaneous Elranatamab in the Patients' Homes.
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA
Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests
- Status
- UNKNOWN
- Phase
- NA
Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
- Status
- RECRUITING
- Phase
- N/A
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- NA
Helical Tomotherapy in Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Myeloma Novel Drug Discovery Ver 1.2
- Status
- RECRUITING
- Phase
- N/A
The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study
- Status
- RECRUITING
- Phase
- N/A
Telemonitoring Among Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- NA
Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA